{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:46:15Z","timestamp":1792586775895,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.meegid.2018.04.005","type":"journal-article","created":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T20:31:30Z","timestamp":1522960290000},"page":"185-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"special_numbering":"C","title":["Current epidemiology, genetic evolution and clinical impact of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8804-3181","authenticated-orcid":false,"given":"Yong","family":"Chong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2018.04.005_bb0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ijantimicag.2017.07.003","article-title":"Bloodstream infections due to extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis","volume":"50","author":"Alevizakos","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2018.04.005_bb0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1473-3099(16)30319-X","article-title":"Import and spread of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study","volume":"17","author":"Arcilla","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0015","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/jac\/dkx146","article-title":"Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype","volume":"72","author":"Bevan","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijantimicag.2017.02.010","article-title":"Antimicrobial susceptibility and mechanisms of fosfomycin resistance in extended-spectrum \u03b2-lactamase-producing Escherichia coli strains from urinary tract infections in Wenzhou, China","volume":"50","author":"Bi","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2018.04.005_bb0025","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/cid\/ciu190","article-title":"Wastewater treatment plants release large amounts of extended-spectrum \u03b2-lactamase-producing Escherichia coli into the environment","volume":"58","author":"Br\u00e9chet","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkw443","article-title":"ESBL\/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage","volume":"72","author":"van den Bunt","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/cid\/ciu864","article-title":"Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections","volume":"60","author":"Can","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.meegid.2018.04.005_bb0040","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/j.ijid.2010.01.004","article-title":"Cefepime-resistant gram-negative bacteremia in febrile neutropenic patients with hematological malignancies","volume":"14","author":"Chong","year":"2010","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0045","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.meegid.2011.06.001","article-title":"Genetic evolution and clinical impact in extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"11","author":"Chong","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2018.04.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054190","article-title":"Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity","volume":"8","author":"Chong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2018.04.005_bb0055","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.05753-11","article-title":"Bacteremia caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality","volume":"56","author":"Chung","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3201\/eid1402.070350","article-title":"Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15","volume":"14","author":"Coque","year":"2008","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/cid\/cis942","article-title":"Community-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli infection in the United States","volume":"56","author":"Doi","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijantimicag.2017.08.003","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and meta-analysis","volume":"50","author":"Flokas","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2018.04.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America","author":"Freifeld","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00164-17","article-title":"Efficacy of \u03b2-lactam\/\u03b2-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae in hematological patients with neutropenia","volume":"61","author":"Gudiol","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/jac\/dkv502","article-title":"Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study","volume":"71","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1473-3099(14)70950-8","article-title":"\u03b2-lactam and \u03b2-lactamase inhibitor combinations in the treatment of extended-spectrum \u03b2-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?","volume":"15","author":"Harris","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.08.021","article-title":"Quantifying within-household transmission of extended-spectrum \u03b2-lactamase-producing bacteria","volume":"23","author":"Haverkate","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.meegid.2018.04.005_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jhin.2015.01.008","article-title":"Multidrug-resistant gram-negative bacteria: a product of globalization","volume":"89","author":"Hawkey","year":"2015","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.meegid.2018.04.005_bb0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.meegid.2018.04.005_bb0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2016.01.008","article-title":"Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: results from the study for monitoring antimicrobial resistance trends (SMART), 2010-2013","volume":"47","author":"Jean","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2018.04.005_bb0115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jac\/dkw398","volume":"72","author":"Jean","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/ciu957","article-title":"Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae","volume":"60","author":"Kantele","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/cid\/ciw283","article-title":"Fecal colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae and risk factors among healthy individuals: a systematic review and metaanalysis","volume":"63","author":"Karanika","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/cid\/ciu785","article-title":"Do human extraintestinal Escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic review","volume":"60","author":"Lazarus","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/cid\/cis1043","article-title":"Public health risks of enterobacterial isolates producing extended-spectrum \u03b2-lactamases or AmpC \u03b2-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options","volume":"56","author":"Liebana","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s15010-012-0269-y","article-title":"Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies","volume":"40","author":"Liss","year":"2012","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.meegid.2018.04.005_bb0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jgar.2015.05.005","article-title":"Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011-2013","author":"Lob","year":"2015","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.meegid.2018.04.005_bb0150","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","article-title":"Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014","volume":"85","author":"Lob","year":"2016","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0155","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1093\/cid\/civ273","article-title":"Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-Spectrum \u03b2-lactamase-producing Escherichia coli sequence type 131","volume":"61","author":"Madigan","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0160","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Mart\u00ednez-Mart\u00ednez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.meegid.2018.04.005_bb0165","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijantimicag.2016.12.013","article-title":"Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes","volume":"49","author":"Morales-Barroso","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.meegid.2018.04.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofx099","article-title":"Comparison between Carbapenems and \u03b2-lactam\/\u03b2-lactamase inhibitors in the treatment for bloodstream infections caused by extended-spectrum \u03b2-lactamase-producing enterobacteriaceae: a systematic review and meta-analysis","volume":"4","author":"Muhammed","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0175","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicolas-Chanoine","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.meegid.2018.04.005_bb0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature17672","article-title":"Interconnected microbiomes and resistomes in low-income human habitats","volume":"533","author":"Pehrsson","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2018.04.005_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/cir793","article-title":"Can we really use \u00df-lactam\/\u00df-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum \u00df-lactamase-producing bacteria?","volume":"54","author":"P\u00e9rez","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0190","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1322678111","article-title":"Global dissemination of a multidrug resistant Escherichia coli clone","volume":"111","author":"Petty","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2018.04.005_bb0195","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/521260","article-title":"Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia","volume":"45","author":"Reddy","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2018.04.005_bb0205","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cid\/civ333","article-title":"High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics","volume":"61","author":"Rupp\u00e9","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.04.005_bb0210","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1128\/AAC.01071-15","article-title":"Clinical appraisal of Fosfomycin in the era of antimicrobial resistance","volume":"59","author":"Sastry","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0215","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1001\/jama.2008.896","article-title":"Carbapenem-resistant Enterobacteriaceae: a potential threat","volume":"300","author":"Schwaber","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.meegid.2018.04.005_bb0220","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: a multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.meegid.2018.04.005_bb0225","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01094-17","article-title":"Use of \u03b2-lactam\/\u03b2-lactamase inhibitors for extended-spectrum-\u03b2-lactamase infections: defining the right patient population","volume":"61","author":"Tamma","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2018.04.005_bb0230","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1473-3099(12)70317-1","article-title":"The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria","volume":"13","author":"Wellington","year":"2013","journal-title":"Lancet Infect. Dis."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818301783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818301783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T13:55:11Z","timestamp":1534946111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134818301783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":46,"alternative-id":["S1567134818301783"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2018.04.005","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current epidemiology, genetic evolution and clinical impact of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2018.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}